Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, I rarely disagree on any of your posts. With this one I agree with Kiwi that
a combo drug for the purpose of reestablishing exclusivity in the US would be a
waste. The only way it might work is if BP were the owner and rebranded it.
However, I would hope that if a BP owned AMRN they would consider rebranding
Vascepa (as an AG) and point out why their product was safer than an untested
generic. My thesis on Vascepa is that it is a far more valuable product in the hands
of a Euro-centric BP (especially for its value in Europe) than it ever could be as
a JV or GIA mode.) Where you could end up being right is if a combo drug
were developed as a "one a day" product.

Regardless, none of us have the full information or expertise to make the right
call on this. (I am not so sure that KM does either.) So far I am disappointed by
KM. The key question now is what does Denner have planned and will he succeed!
My guess (and only real hope) is that Denner will engineer a BP BO.